Juq-565 Page

General procedure for quinazolinone formation: 2‑Aminobenzamide (1.0 eq) was condensed with 4‑fluorobenzoyl chloride (1.2 eq) in dry dichloromethane (DCM) in the presence of triethylamine (2 eq) at 0 °C → rt (4 h). Cyclization was achieved by heating the crude amide in polyphosphoric acid (PPA) at 120 °C for 2 h, affording the quinazolinone core (95 % yield).

Installation of the pyridyl‑methyl side chain: The quinazolinone (1.0 eq) was deprotonated with NaH (1.5 eq) in DMF, then reacted with 2‑(bromomethyl)pyridine (1.2 eq) at 80 °C (6 h). The product was purified by flash chromatography (gradient EtOAc/hexanes) to give JUQ‑565 (84 % isolated yield).

All intermediates were characterized by ¹H/¹³C NMR, HR‑MS, and elemental analysis. The final compound showed > 99 % purity by HPLC (UV 254 nm).

The PI3K‑Akt signaling cascade is a central node regulating cell growth, survival, and metabolism. Hyperactivation of PI3Kα—commonly driven by PIK3CA mutations or PTEN loss—is a hallmark of many solid tumors, notably triple‑negative breast cancer (TNBC) where therapeutic options remain limited. While several PI3Kα inhibitors have entered clinical testing (e.g., alpelisib), dose‑limiting toxicities and limited efficacy in TNBC underscore the need for novel agents with improved selectivity, pharmacokinetics, and combinatorial potential. JUQ-565

JUQ‑565 emerged from a phenotypic screen of ~2 × 10⁶ small molecules designed to suppress Akt phosphorylation in a PIK3CA‑mutant TNBC line (MDA‑MB‑468). Preliminary hits exhibited a quinazolinone‑pyridine core, prompting a focused SAR campaign that culminated in JUQ‑565 (Figure 1). The molecule combines a 4‑fluorophenyl substituent at the quinazolinone C‑2 position with a 2‑pyridyl‑methyl side chain, conferring high affinity for the ATP‑binding pocket of PI3Kα while minimizing off‑target kinase interactions.

In this paper we provide a detailed account of (i) the convergent synthetic route to JUQ‑565, (ii) in‑vitro pharmacology and SAR expansion, (iii) ADME and pharmacokinetic (PK) characterization, (iv) efficacy in orthotopic xenograft models, and (v) mechanistic insights into synergy with DNA‑damaging agents. The work demonstrates that JUQ‑565 fulfills key criteria for a first‑in‑class, orally active PI3Kα inhibitor with a therapeutic window suitable for further clinical development.

If "JUQ-565" refers to implementing a search functionality in a web application: If "JUQ-565" refers to implementing a search functionality

Without specific details on "JUQ-565," this approach provides a general framework for feature development.

Unveiling the Enigma: Understanding JUQ-565

In recent times, the designation "JUQ-565" has emerged, capturing the attention of various circles. While the specific context or field it relates to might not be widely known, delving into the potential significance and implications of such a designation can offer insights into areas ranging from scientific research to technological advancements. This article aims to inform readers about JUQ-565, exploring its possible meanings, relevance, and the speculation surrounding it. Without specific details on "JUQ-565

A laboratory testbed (10 km fiber spool) demonstrated a raw detection rate of 45 Mcps and an effective secret‑key rate of 7.8 Gbps after error correction and privacy amplification. The measured QBER was 1.9 %, confirming the predicted tolerance margin. Crucially, the adaptive LDPC module reduced the number of required decoding iterations from a worst‑case 30 to an average of 7, cutting latency to < 2 µs per block.

The advent of large‑scale, fault‑tolerant quantum computers threatens the security of virtually all public‑key cryptographic schemes currently deployed on the Internet. While post‑quantum cryptography (PQC) offers a near‑term mitigation path, the only provably secure alternative is quantum‑key distribution (QKD), which exploits the no‑cloning theorem and the monogamy of entanglement to achieve information‑theoretic secrecy. Traditional QKD implementations—most notably BB84 and its variants—are limited by low key‑generation rates, stringent hardware requirements, and vulnerability to side‑channel attacks.

JUQ‑565 was conceived to address these shortcomings. It combines three core innovations:

Together, these advances enable secret‑key rates exceeding 10 Gbps over metropolitan‑scale fiber links while maintaining a QBER ceiling of 3 %, well below the security threshold for high‑dimensional QKD.